Cargando…
Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
PURPOSE: The aim of this study was to analyze data on gabapentinoid-related attendances to the National Poison Control Center of Serbia (NPCC), particularly abuse cases; to estimate its changes and to compare it with trends in national consumption rates of these drugs. We also aimed to analyze the m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094400/ https://www.ncbi.nlm.nih.gov/pubmed/37065979 http://dx.doi.org/10.2147/IJGM.S405616 |
_version_ | 1785023832747147264 |
---|---|
author | Antunovic, Marko Vucinic, Slavica Kotur-Stevuljevic, Jelena Krstic, Kristijan Jovic-Stosic, Jasmina Kilibarda, Vesna Perkovic-Vukcevic, Natasa Djordjevic, Snezana |
author_facet | Antunovic, Marko Vucinic, Slavica Kotur-Stevuljevic, Jelena Krstic, Kristijan Jovic-Stosic, Jasmina Kilibarda, Vesna Perkovic-Vukcevic, Natasa Djordjevic, Snezana |
author_sort | Antunovic, Marko |
collection | PubMed |
description | PURPOSE: The aim of this study was to analyze data on gabapentinoid-related attendances to the National Poison Control Center of Serbia (NPCC), particularly abuse cases; to estimate its changes and to compare it with trends in national consumption rates of these drugs. We also aimed to analyze the main characteristics of the study population and to investigate the major clinical effects in poisoned patients. PATIENTS AND METHODS: This is a retrospective study of patients admitted to the NPCC for acute poisoning involving gabapentinoids from 1 May 2012 to 1 October 2022. RESULTS: There were 357 (95.5%) pregabalin-related and 17 (4.5%) gabapentin-related poisoning cases in 302 patients. Abuse of pregabalin was detected in 27.8% (84/302), while gabapentin abuse occurred in 0.7% (2/302) of all patients. A steady increase in rates of pregabalin poisoning and abuse cases strongly correlated with the increase in overall consumption of this drug, while there were no significant changes in rates of gabapentin consumption, poisoning and abuse rate during the study period. Most patients who abused pregabalin pregabalin were males (84.5%) and the median age was 26 years (range: 15–45 years). Almost 60% of patients who abused pregabalin (48/84) belonged to the migrant population. Co-ingestions occurred in 89.4% of pregabalin-related cases (319/357), resulting in more severe poisoning. The most often co-ingested drugs were benzodiazepines and among them clonazepam was detected in the largest number of cases. CONCLUSION: The poisoning and abuse cases involving pregabalin are on the rise in Serbia, which coincided with an increase in its overall consumption during the study period. Isolated pregabalin ingestions resulted in mild poisoning, although severe symptoms such as coma and bradycardia were recorded. When prescribing pregabalin to patients at risk of abuse caution is needed. Strengthening the measures for dispensing of pregabalin may reduce the risks associated with its abuse. |
format | Online Article Text |
id | pubmed-10094400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100944002023-04-13 Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study Antunovic, Marko Vucinic, Slavica Kotur-Stevuljevic, Jelena Krstic, Kristijan Jovic-Stosic, Jasmina Kilibarda, Vesna Perkovic-Vukcevic, Natasa Djordjevic, Snezana Int J Gen Med Original Research PURPOSE: The aim of this study was to analyze data on gabapentinoid-related attendances to the National Poison Control Center of Serbia (NPCC), particularly abuse cases; to estimate its changes and to compare it with trends in national consumption rates of these drugs. We also aimed to analyze the main characteristics of the study population and to investigate the major clinical effects in poisoned patients. PATIENTS AND METHODS: This is a retrospective study of patients admitted to the NPCC for acute poisoning involving gabapentinoids from 1 May 2012 to 1 October 2022. RESULTS: There were 357 (95.5%) pregabalin-related and 17 (4.5%) gabapentin-related poisoning cases in 302 patients. Abuse of pregabalin was detected in 27.8% (84/302), while gabapentin abuse occurred in 0.7% (2/302) of all patients. A steady increase in rates of pregabalin poisoning and abuse cases strongly correlated with the increase in overall consumption of this drug, while there were no significant changes in rates of gabapentin consumption, poisoning and abuse rate during the study period. Most patients who abused pregabalin pregabalin were males (84.5%) and the median age was 26 years (range: 15–45 years). Almost 60% of patients who abused pregabalin (48/84) belonged to the migrant population. Co-ingestions occurred in 89.4% of pregabalin-related cases (319/357), resulting in more severe poisoning. The most often co-ingested drugs were benzodiazepines and among them clonazepam was detected in the largest number of cases. CONCLUSION: The poisoning and abuse cases involving pregabalin are on the rise in Serbia, which coincided with an increase in its overall consumption during the study period. Isolated pregabalin ingestions resulted in mild poisoning, although severe symptoms such as coma and bradycardia were recorded. When prescribing pregabalin to patients at risk of abuse caution is needed. Strengthening the measures for dispensing of pregabalin may reduce the risks associated with its abuse. Dove 2023-04-08 /pmc/articles/PMC10094400/ /pubmed/37065979 http://dx.doi.org/10.2147/IJGM.S405616 Text en © 2023 Antunovic et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Antunovic, Marko Vucinic, Slavica Kotur-Stevuljevic, Jelena Krstic, Kristijan Jovic-Stosic, Jasmina Kilibarda, Vesna Perkovic-Vukcevic, Natasa Djordjevic, Snezana Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study |
title | Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study |
title_full | Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study |
title_fullStr | Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study |
title_full_unstemmed | Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study |
title_short | Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study |
title_sort | rise of pregabalin poisoning and abuse cases in serbia: a ten-year retrospective study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094400/ https://www.ncbi.nlm.nih.gov/pubmed/37065979 http://dx.doi.org/10.2147/IJGM.S405616 |
work_keys_str_mv | AT antunovicmarko riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT vucinicslavica riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT koturstevuljevicjelena riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT krstickristijan riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT jovicstosicjasmina riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT kilibardavesna riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT perkovicvukcevicnatasa riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy AT djordjevicsnezana riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy |